When the Biomedical Industry Can’t Prioritize Diseases, Private Money Can Save Lives
Release Date:
09/19/2014
... affects at least 25 million Americans.) Given the expense of research, development, and bringing a new device or drug ... and disease advocacy groups can catalyze the development of new therapies and...